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1. Introduction
Screening of body fluids - usually urine, plasma/
serum or whole blood - is performed in overdosing on 
unknown drugs [1]. In some emergencies quick and 
automated immunoassays which do not require special 
sample preparation are used. However, these only 
determine some drug groups (e.g. benzodiazepines, 
tricyclic antidepressants) and confirmation should be 
performed by HPLC or capillary electrophoresis (CE) 
[1]. Despite advances in instrumental techniques, drug 
determinations in biological samples are usually preceded 
by pretreatment to isolate and concentrate the drugs; 
chromatographic and electrophoretic instruments cannot 
handle the matrix. Classic liquid-liquid extraction (LLE) 
and solid-phase extraction (SPE) are most commonly 
employed [1].
Paracetamol, amitriptyline, nortriptyline, promazine, 
chlorpromazine and clomipramine are also usually 
isolated from biological material using SPE or LLE, 
and determined by HPLC/UV(DAD). Amitriptyline, 
nortriptyline and clomipramine have been extracted from 
human plasma on Isolute C2 cartridges with recoveries of 
81±3.1%, 95±5.0% and 101±6.2%, respectively [2], then 
determined together with other tricyclic antidepressants 
and their metabolites by HPLC/UV. In combination with 
SPE an HPLC/UV method using Isolute cyanopropyl (CN) 
cartridges [3] was applied to simultaneous analysis of 
classical neuroleptics (including chlorpromazine), atypical 
neuroleptics, and their metabolites in human plasma. 
Extraction yields were all ≥ 93%. Five antipsychotic 
drugs, including promazine, were simultaneously 
determined in rat plasma by HPLC/UV after an LLE acid 
back extraction using isopropyl ether-pentane [4]. The 
extraction yield for promazine was ca. 100% with intra-
day and inter-day precisions (RSD) ca. 3.6% and 4.3%. 
Liquid-liquid extraction with 2-propanol-chloroform was 
also successfully employed in isolation and determination 
of paracetamol and its toxic metabolite N-acetyl-p-
benzoquinoneimine in pediatric plasma [5]. Along with 
the advantages of long experience, good recovery and 
repeatability, these techniques also require substantial 
time, consume large amounts of toxic organic solvents, 
or require relatively expensive extraction columns.
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Cloud-point extraction (CPE) with RP-HPLC/DAD detection was used to develop a screen for six model basic drugs (paracetamol, 
promazine, amitriptyline, nortriptyline, clomipramine and chlorpromazine) in human plasma. These drugs’ varied hydrophobicities 
entail different affinities for the micelle-rich phase and CPE extraction efficiencies. Extraction recovery (except paracetamol) was 
above 80% and reproducibility (RSD%) ranged from 2.88 to 10.26 intraday and from 3.12 to 12.33 interday. The limits of detection 
were: 0.125 µg mL-1 (promazine and chlorpromazine), 0.25 µg mL-1 (amitriptyline and nortriptyline) and 0.5 µg mL-1 (paracetamol 
and clomipramine). The method was linear over the ranges: 0.125 -1.0 µg mL-1 (promazine and chlorpromazine), 0.25-1.0 µg mL-1 
(amitriptyline and nortriptyline), 0.5-1.0 µg mL-1 (clomipramine) and 0.5-10 µg mL-1 (paracetamol). The procedure is a good alternative 
to the SPE or LLE sample preparation usually used.
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Micelle-mediated extraction (MME), especially cloud-
point extraction (CPE), seems to be a good alternative 
to conventional LLE and SPE. Its chief advantages 
are simplicity, speed, low cost, and compatibility with 
common HPLC mobile phases and CE background 
electrolytes, as well as the environmentally benign 
character of the surfactants.
In CPE a micellar phase is formed from a 
homogenous surfactant solution added to the sample. 
Surfactants aggregate into micelles, orienting their 
hydrocarbon tails toward the center creating a non-
polar core. Hydrophobic compounds (most drugs) are 
favorably partitioned into that hydrophobic core. Phase 
separation into a micelle-rich phase and an aqueous 
phase containing surfactant near the critical micelle 
concentration requires a temperature change for non-
ionic and zwitterionic surfactants (CPE). Changing 
other parameters (e.g. pH, ionic salt or organic solvent 
addition) yields phase separations with ionic surfactants 
[6].
A number of papers concerning drug determination 
using CPE (usually a single drug) in human urine 
[7-11], human serum [12-14] and rat plasma [15-17] 
have appeared in the last decade. In most reports, 
liquid chromatography with fluorimetric detection or UV 
detection above 280 nm was used. GC-MS has also 
been used, but additional cleanup was required [13]. To 
our knowledge, only paracetamol and chlorpromazine 
among the six drugs investigated here have been 
concentrated from body fluids by CPE. Paracetamol 
in urine was determined as the blue derivative of its 
hydrolysis product with tetrahydroxycalic[4]arene 
by conventional spectrophotometry after CPE with 
Triton X-114 [10]. For spiked and real urine samples 
the recoveries were 100±3%. The phenothiazines 
pericyazine, chlorpromazine and fluphenazine 
were isolated from spiked human serum and 
separated from the Triton X-114 by passing the 
surfactant–rich phase through a cation exchange column 
permitting determination by GC-FID [13]. The recoveries 
of pericyazine, chlorpromazine and fluphenazine 
were 95.1±3.3%, 87.1±6.3% and 84.7±2.7%, 
respectively.
The objective of this work was to test cloud-point 
extraction for toxicologic screening of basic drugs in 
human plasma. Six drugs: paracetamol, promazine, 
chlorpromazine, nortriptyline, amitriptyline and 
clomipramine were selected, representing a large 
group of basic drugs (pKa > 9) with a wide range of 
hydrophobicity. The procedure was applied to HPLC-
DAD screening for these compounds in plasma, and 
appropriate validation parameters were determined. 
The drug structures, molecular weights, dissociation 
constants (pKa) and octanol-water partition coefficients 
(logP) are in Table 1.
2. Experimental procedure
2.1. Apparatus         and        chromatographic  
       conditions
A Merck-Hitachi (Darmastadt, Germany) LaChrom 
chromatographic system, consisting of an L-7100 pump 
and an L-7455 programmable diode array detector 
(DAD) was used with a Merck Nucleosil C8 column 
(250×4.6 mm i.d., 5µm) thermostated at 25ºC. A Vibra 
Cell ultrasonic bath and FreeZone 11 lyophilizer were 
from Sonics & Materials Inc. (USA) and Labconco 
(USA), respectively. The samples were centrifuged 
using an MPW-6 ultracentrifuge (Mechanika Precyzyjna, 
Poland).
Gradient chromatography used mobile phase A: 
0.002M aqueous orthophosphoric acid, and phase 
B:  acetonitrile. The gradient profile was: 0 min: 100% 
A, 0-30 min: 30% A and 70% B and 30-33 min: 100% A. 
The flow rate was 1mL min-1. The drugs were detected 
by UV absorption at 254 nm. 
2.2. Reagents
HPLC-gradient grade acetonitrile and methanol were 
supplied by Merck (Germany)  and Triton X-114 were 
purchased from Sigma-Aldrich (Germany). The 85% 
orthophosphoric acid, 30% sodium hydroxide, and 
25% ammonia, all of analytical grade, were purchased 
from POCH (Poland). Doubly deionized water 
(<1.0 µS cm-1) was used throughout. 
2.3. Drugs and Materials
Amitriptyline, nortriptyline, clomipramine and 
paracetamol were purchased from Sigma-Aldrich 
(Germany), and promazine and chlorpromazine were 
obtained from the Jelfa pharmaceutical factory (Poland). 
A stock solution of each drug (10 mg mL-1) was prepared 
in methanol and stored at 4ºC. Working drug solutions 
were prepared by dilution of the stock drug solutions with 
a 1:1 (v/v) mixture of phases A and B. Human plasma 
was obtained from the Krakow, Poland blood bank. This 
plasma was spiked with water-diluted standard drugs to 
obtain the control samples.
2.4. Sample Preparation
Plasma (1 mL) was mixed with 1 mL of 7.5% (w/v) 
Triton X-114, adjusted to pH 12 and incubated at 25°C 
for 20 min. Centrifugation (13,000 rpm for 10 min) was 
performed and the sample was cooled in an ice bath for 
5 min. The upper aqueous phase was decanted and the 
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micelle-rich phase containing the drugs was evaporated 
under a nitrogen stream in a hot block at 40°C for 
30 min. The dried micellar phase was dissolved in 150 
µL of acetonitrile. 
3. Results and discussion
Paracetamol, promazine, amitriptyline and 
chlorpromazine were used to optimize the CPE 
conditions. Sample pH, surfactant concentration, 
centrifugation speed and time, as well as the micellar 
phase evaporation method were optimized. However, 
incubation temperature (25°C), incubation time 
(20 min), and acetonitrile volume (150 µL) were based 
on previous work [18]. The degree of drug recovery was 
the main optimization criterion.
3.1. Study of CPE conditions 
3.1.1. Effect of sample pH
The effect of sample pH was examined applying the 
above procedure using 7.5% (w/v) Triton X-114 at pH 
8.0, 10.0 and 12.0. The average extraction recoveries 
(4 replicates) are in Fig. 1, and the optimal sample pH 
12 was used in further experiments.
3.1.2. Effect of surfactant concentration
Surfactant concentration is a compromise between 
preconcentration and a resulting surfactant-rich phase 
volume sufficient to make reproducible extractions. 
Drug recovery was examined at five surfactant 
concentration levels: 0.94, 1.88, 3.75, 7.5 and 10.0% 
(w/v). The average extraction recoveries (4 replicates) 
are in Fig. 2. From 1.88 to 7.5% the extraction recovery 
for promazine, amitriptyline and chlorpromazine was 
Figure 1. Effect of sample pH on extraction recovery from aqueous standard solutions (each drug at 1 µg mL-1).
Figure 2. Effect of surfactant concentration (Triton X-114) on extraction recovery from aqueous standard solutions (each drug at 1 µg mL-1).
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a) molecular mass of hydrochloride salt 
b) participation coefficient (octanol/buffer 7.4)
c) lack of literature data
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high and ranged from above 80 to ca. 100%. However, 
for the less hydrophobic paracetamol (smallest logP) 
the extraction recovery was < 10%. It was better 
extracted at considerably higher surfactant levels;  ca. 
30% recovery was achieved using 10.0% Triton X-114, 
while at this surfactant concentration the recoveries 
of the rest (except promazine; logP = 2.5) were 
lower (Fig. 2). Considering the relatively high 
concentrations of paracetamol in plasma and whole 
blood (therapeutic plasma concentrations range 
10-20 µg mL-1), the recovery (ca. 20 %) was sufficient 
for screening. Finally, 1 mL of 7.5% (w/v) Triton X-114 
was selected.
3.1.3. Effect of centrifugation
The influence of centrifugation speed and time were 
examined. Three speeds (4500 rpm, 8000 rpm and 
13000 rpm) and three times (5, 10 and 15 min) were 
tested. Higher centrifugation speed (especially 
13000 rpm) gave better micellar phase adhesion to the 
tube walls. The centrifuge did not allow higher speed. 
Centrifugation time was of less significance. As the final 
centrifugation parameters 13000 rpm and 10 min were 
chosen.
3.1.4. Methods   for   micelle-rich   phase   quantitative 
          evaporation
Handling the micellar phase containing the isolated 
drugs is critical for CPE reproducibility. Complete 
removal of water traces is usually by evaporation under 
nitrogen flow [6].
Two methods for quantitative removal of water from 
the micelle-rich phase after decantation of the upper 
aqueous phase were examined: 
1) evaporation under nitrogen flow using a hot block 
(25ºC) for 20 min.
2) lyophilization for ca. 24 hours.
Using conventional heating incomplete decantation 
and dehydration caused scatter in the results. To 
improve reproducibility and improve the chromatograms 
for method (1) (separation quality strongly depended on 
quantitative water removal) the temperature was raised 
from 25 to 40ºC and the drying time increased from 20 
to 30 min. 
Lyophilization was performed in liquid nitrogen at 
-50ºC. The lyophilates were dissolved in acetonitrile 
(150 µL) in an ultrasonic bath for 10 minutes then 
analyzed.
The mean recoveries (4 replicates) for paracetamol, 
promazine, amitriptyline and chlorpromazine are in 
Fig. 3. Lyophilization gave recoveries similar to those 
from conventional heating with evaporation under 
nitrogen. Considering the time required for lyophilization 
the first method was chosen. 
3.2. 
The CPE procedure was applied to the six basic drugs 
paracetamol, amitriptyline, nortriptyline, promazine, 
chlorpromazine and clomipramine in human plasma. 
Example chromatograms of a standard drug mixture, 
Figure 3. Effect of the micelle-rich phase treatment method. Method I: decantation of the upper aqueous phase and evaporation of the micellar 
phase at 40ºC in flowing nitrogen for 30 min. Method II: decantation of the upper aqueous phase and lyophilization of the micellar 
phase for 24 hours.
Validation of the CPE-HPLC/DAD method 
for HPLC determination of six basic drugs 
in plasma samples
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a plasma extract containing the six drugs, and a blank 
plasma extract after optimized CPE are in Fig. 4.
The extraction recoveries, reproducibility (intraday 
and interday), detection limit and linearity ranges are 
in Table 2. The retention times and their intraday and 
interday precisions were also determined.
The experimental conditions yield good 
separation for all the drugs examined and the 
Triton X-114. The plasma matrix does not interfere 
with analyte peaks (Fig. 4), so the selectivity is 
satisfactory.
To determine drug recovery the plasma was 
spiked with paracetamol, promazine, amitriptyline, 
chlorpromazine, nortriptyline and clomipramine at 
1 µg mL-1 each, then submitted to CPE-HPLC. 
Extraction recovery was determined from the peak 
Table 2. CPE-HPLC/DAD method validation parameters for determination of the six basic drugs in plasma. 
Parameter Plasma
Paracet Promaz Nortript Amitript Chlorpro Clomipra
Retention time (RT) 
[min] 7.09 17.40 18.01 18.50 19.29 20.11
Intraday RT precision 
[RSD, %]  (n=4) 0.003 0.008 0.005 0.006 0.008 0.013
Interday RT precision 
[RSD, %]  (n=4) 0.010 0.013 0.015 0.072 0.077 0.086
Extraction recovery 
(ER) [%] 22.08 94.11 103.66 91.98 86.28 82.49
Intraday ER precision 
[RSD, %] (n=4) 10.26 4.24 2.88 4.40 4.72 7.50
Interday ER precision 
[RSD, %]  (n=4) 12.33 4.95 3.12 5.21 5.25 8.78
Linearity range
[µg mL-1] 0.5-10.0 0.125-1.0 0.25-1.0 0.25-1.0 0.125-1.0 0.5-1.0
Correlation coefficient r2 0.9976 0.9951 0.9974 0.9896 0.9989 0.9974
Detection limit 
(LOD) [µg mL-1] 0.5 0.125 0.25 0.25 0.125 0.5
Figure 4. Post-CPE chromatograms of a standard drug mixture, a blank plasma sample, and a plasma sample spiked with the six tested drugs 
at 1µg mL-1: 1– paracetamol, 3 – promazine, 4 – nortriptyline, 5 – amitriptyline, 6 – chlorpromazine, 7 – clomipramine, 2 and 8 – 
unidentified.
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area ratio of plasma extract:standard. The standard 
concentration corresponded to the theoretical value 
of the sample CPE extract using the drug concentration 
coefficient (sample volume/acetonitrile volume) was 
corrected by the measured (using a Hamilton syringe) 
micelle-rich phase volume. 
For reproducibility determination two series (over two 
days) of four plasma samples containing the drugs were 
extracted and analyzed. The relative standard deviation 
(RSD%) . was calculated.
To determine LODs plasma was spiked with the 
standard drugs at four concentrations: 0.125, 0.25, 0.5 
and 1 µg mL-1 (except paracetamol, which was spiked 
at 0.25, 0.5, 2, 5 and 10 µg mL-1) and then subjected 
to CPE-HPLC. The LOD for each drug was calculated 
as its concentration corresponding to its peak area ≥ 3x 
baseline noise.
The linear range for each drug was also determined; 
correlation coefficients are in Table 2.
4. Conclusions
The following conclusions were drawn:
- the CPE technique is satisfactory for plasma 
sample preparation for HPLC-UV(DAD), drug screening 
for hydrophobic compounds. Less hydrophobic drugs 
(e.g. paracetamol) may be also determined at sufficiently 
high concentrations,.
- the drugs tested may be determined at high 
therapeutic or low toxic plasma concentrations.
- the detection limit for some drugs (amitriptyline, 
nortriptyline and clomipramine) may be lowered at 
least twofold if another wavelength (e.g. 210 nm) is 
chosen; however, matrix interference peaks must be 
considered.
CPE is a good alternative to the routine extraction 
techniques like LLE or SPE in toxicological drug 
screening because of its analytical parameters as well 
as its simplicity, speed, low cost and “green” character.
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